Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

33 results about "Pratylenchus" patented technology

Pratylenchus is a genus of nematodes known commonly as lesion nematodes. They are parasitic on plants and are responsible for root lesion disease on many taxa of host plants in temperate regions around the world. Lesion nematodes are migratory endoparasites that feed and reproduce in the root and move around, unlike the cyst or root-knot nematodes, which may stay in one place. They usually only feed on the cortex of the root. Species are distinguished primarily by the morphology of the stylets.

Mutant ROS Expression In Human Cancer

ActiveUS20110287445A1Drive proliferationDrive survivalOrganic active ingredientsPeptide/protein ingredientsNucleotideADAMTS Proteins
The invention provides the identification of the presence of mutant ROS protein in human cancer. In some embodiments, the mutant ROS are FIG-ROS fusion proteins comprising part of the FIG protein fused to the kinase domain of the ROS kinase. In some embodiments, the mutant ROS is the overexpression of wild-type ROS in cancerous tissues (or tissues suspected of being cancerous) where, in normal tissue of that same tissue type, ROS is not expressed or is expressed at lower levels. The mutant ROS proteins of the invention are anticipated to drive the proliferation and survival of a subgroup of human cancers, particularly in cancers of the liver (including bile duct), pancreas, kidney, and testes. The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant ROS polypeptides (e.g., a FIG-ROS(S) fusion polypeptide), probes for detecting it, isolated mutant polypeptides, recombinant polypeptides, and reagents for detecting the fusion and truncated polypeptides. The identification of the mutant ROS polypeptides enables new methods for determining the presence of these mutant ROS polypeptides in a biological sample, methods for screening for compounds that inhibit the proteins, and methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides, which are also provided by the invention.
Owner:CELL SIGNALING TECHNOLOGY

Natural passage cell line for lamb testis sertoli cells and application of natural passage cell line to separate culture and proliferation of goatpox viruses

ActiveCN106222131AAvoid the risk of carrying other pathogensQuality improvementCell dissociation methodsViral antigen ingredientsPrimary cellTesticle
The invention discloses a natural passage cell line for lamb testis sertoli cells and application of the natural passage cell line to separate culture and proliferation of goatpox viruses. The cell line disclosed by the invention is a lamb testis sertoli natural passage cell line which is obtained by separating and purifying primary cells of a lamb testis to obtain the lamb testis sertoli cells and performing natural passage on the lamb testis sertoli cells. A research shows that the cell line is relatively sensitive to inoculation of the goatpox viruses; the virus titer proliferated by the cell line is greater than that of the primary cells, Vero cells and BHK21 cells of the testis of a newborn lamb by about 1.5, 2.5 and 2.3 respectively. The cell line for separating the goatpox viruses can guarantee the uniformity and the stability of the viruses and prevent the risk that the separated viruses carry other pathogenies due to the fact that the primary cells are used for multiple times. Furthermore, by the use of the passage cell line for preparing vaccines, the production process is simplified, the production period is shortened, and the production cost is reduced; meanwhile, the quality of the vaccines are kept stable; the cell line has certain practical significance for large-scale production of the vaccines.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Method and special primer for rapidly breeding ST (swine testis) sensitive cell lines of hog cholera virus lapinized virus strain (C strain)

The invention discloses a method for rapidly breeding ST (swine testis) sensitive cell lines of a hog cholera lapinized virus strain (C strain) by virtue of a reverse transcription PCR (RT-PCR) (reverse transcription-polymerase chain reaction) technology and a real-time fluorescent quantitative RT-PCR technology. The method comprises the following steps: 1) acquiring ST monoclonal cells; 2) inoculating the hog cholera lapinized virus strain (C strain); 3) extracting RNAs of various batches of hog cholera lapinized virus liquid (virus liquid) which are continuously harvested, and determining that ST monoclonal cell lines can continuously infect the hog cholera lapinized virus strain (C strain) by virtue of the RT-PCR technology; and 4) determining that the hog cholera lapinized virus strain of which the number of copies is 10<6> copies/mL or above are the ST sensitive cell lines of the hog cholera lapinized virus strain (C strain) by virtue of the real-time fluorescent quantitative RT-PCR technology. With the application of the method disclosed by the invention, the sensitive cell lines can be rapidly provided for the production of hog cholera lapinized virus vaccines, so that a vaccine production cycle is shortened and vaccine cost is reduced.
Owner:JINYUBAOLING BIO PHARMA CO LTD

Nutrient product containing chicken testes, cockscombs and epimedium herb

The invention relates to a a nutrient product, and specifically discloses a nutrient product containing chicken testes, cockscombs and epimedium herb. The nutrient product containing the chicken testes, the cockscombs and the epimedium herb comprises the following ingredients: 1-20 parts of chicken testes, 1-20 parts of cockscombs, 1-20 parts of epimedium herb, 1-3 parts of deer whips, 1-3 parts of pilose antlers, 1-20 parts of sea horses, 1-10 parts of radix polygoni multiflori, 1-5 parts of ginseng, 1-10 parts of red dates, 1-10 parts of honey, 1-10 parts of sambucus chinensis, and 1-10 parts of stalactite. The chicken testes, the cockscombs and the epimedium herb are adopted as main main materials of the nutrient product; and the deer whips, the pilose antlers, the sea horses, the sambucus chinensis and the like are adopted as auxiliary materials. The nutrient product containing the chicken testes, the cockscombs and the epimedium herb are mainly used for treating impotence of the male, as well as the syndromes of infertility, irregular menstruation, premature aging of the face, premature climacteric, endocrine disorder and the like caused by liable cold womb of the female; andthe nutrient product is also capable of supplementing hormone of the male so as to invigorating Yang and tonifying the kidney, and thus, performance of the reproductive system can be improved. Moreoverr, the nutrient product containing the chicken testes, the cockscombs and the epimedium herb has good health-caring functions, and is convenient and safe for eating.
Owner:上海茂久中医药科技有限公司

Combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and production method of combined inactivate vaccine

The invention relates to a combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and a production method of the combined inactivate vaccine. The method comprises thesteps of inoculating suspension cultured BHK-21 cells and a proper culture medium with a capripox virus AV41 strain and a mycoplasma capricolum pneumonia subspecies C87001 strain respectively for culturing, harvesting the culture, concentrating and purifying; inactivating with BEI and thimerosal respectively, adding a suitable adjuvant according to a certain proportion, mixing and emulsifying. The combined inactivate vaccine is used for preventing the sheep pox and the CCPP. The combined inactivate vaccine, provided by the invention, for the sheep pox and the CCPP is obtained internationallyfor the first time, and can achieve the aim of preventing the two diseases by means of one injection; furthermore, a live vaccine for the sheep pox is produced by means of the suspension cultured BHK-21 cells; compared with the original inactivate vaccine prepared from ovine testicular cells, the combined inactivate vaccine provided by the invention has obvious advantages, and can solve the problems that in the production process of the live vaccine for the sheep pox, the sheet testis is difficult to obtain, lamb death and ewe abortion are easily caused, subcutaneous immunization needs to be performed when the vaccine is used, an operation is difficult during clinical application, and the like.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Method by utilizing rabbit-origin cells to produce swine fever live vaccine

The invention relates to a method by utilizing rabbit-origin cells to produce swine fever live vaccine, which comprises the following steps that: selecting cells for producing vaccine, preparing cells for producing vaccine, breeding cell virus strain, breeding venom for producing vaccine, preparing vaccine, split charging and freeze drying. The method is characterized in that: rabbit-origin susceptible cells are used for substituting bovine testicular cells or goat kidney cells to produce swine fever live vaccine, which can solve the pollution problem of external virus from cow and sheep, and by strictly controlling the raw materials and the culture conditions, the purity of the produced vaccine can be guaranteed, and the safety and the effect of the vaccine can be guaranteed; and the rabbit-origin susceptible cells to substitute the transferred cells to manufacture the swine fever live vaccine, so the potential hazard that the transferred cells can cause cancer can be avoided, and the safety of the vaccine is higher. The swine fever cell venom cultured through the method has high content of virus, the antigen tilter is 10 times or more of that of the present vaccine, the immune efficacy of the vaccine can be greatly improved, and the weaknesses of the present vaccine in the clinical use can be overcome.
Owner:南京创启生物科技有限公司

Mutant ROS Expression In Human Cancer

ActiveUS20150119403A1Drive proliferationDrive survivalBiocideMicrobiological testing/measurementNucleotideWild type
The invention provides the identification of the presence of mutant ROS protein in human cancer. In some embodiments, the mutant ROS are FIG-ROS fusion proteins comprising part of the FIG protein fused to the kinase domain of the ROS kinase. In some embodiments, the mutant ROS is the overexpression of wild-type ROS in cancerous tissues (or tissues suspected of being cancerous) where, in normal tissue of that same tissue type, ROS is not expressed or is expressed at lower levels. The mutant ROS proteins of the invention are anticipated to drive the proliferation and survival of a subgroup of human cancers, particularly in cancers of the liver (including bile duct), pancreas, kidney, and testes. The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant ROS polypeptides (e.g., a FIG-ROS(S) fusion polypeptide), probes for detecting it, isolated mutant polypeptides, recombinant polypeptides, and reagents for detecting the fusion and truncated polypeptides. The identification of the mutant ROS polypeptides enables new methods for determining the presence of these mutant ROS polypeptides in a biological sample, methods for screening for compounds that inhibit the proteins, and methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides, which are also provided by the invention.
Owner:CELL SIGNALING TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products